GeneChem

Venture capital firm from Quebec, Canada investing in companies that are involved in drug discovery and development

All edits

Edits on 17 Jun, 2020
Golden AI
Golden AI edited on 17 Jun, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Investors
InnoSpring
Edits on 18 Mar, 2020
Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 18 Mar, 2020
Edits made to:
Article (+20/-20 characters)
Article

GeneChem is a venture capital firmventure capital firm that centers on biotechnology venture capital funds. They have over $350M in assets circulated in four funds: GeneChem Technologies, GeneChem Therapeutics, Agechem and AmorChem. Since 1997, GeneChem has been active in putting resources into companies that are focused on drug discovery and development. They have put resources into more than 60 companies situated in the US, Canada and Europe.

Edits on 22 Nov, 2019
Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia edited on 22 Nov, 2019
Edits made to:
Timeline (+1 events) (+7 characters)
Timeline

1997

Founded

Edits on 11 Nov, 2019
Carla Faraguna
Carla Faraguna edited on 11 Nov, 2019
Edits made to:
Infobox (+2 properties)
Article (+12/-11 characters)
Article

GeneChem is a venture capitacapital firm that centers on biotechnology venture capital funds. They have over $350M in assets circulated in four findsfunds: GeneChem Technologies, GeneChem Therapeutics, Agechem and AmorChem. Since 1997, GeneChem has been active in putting resources into companies that are focused on drug discovery and development. They have put resources into more than 60 companies situated in the US, Canada and Europe.

Infobox
Location
Quebec
Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia approved a suggestion from Golden's AI on 11 Nov, 2019
Edits made to:
Article (+6/-6 characters)
Article

GeneChem is headquartered in Montreal, QuebecQuebec. It has an income of $2.5M, and has 10 employees. It has obtained around $44.2M in funds. It has 9 companies in its portfolio. It takes part in everything from seed and startup financings to later stage mezzanine rounds to PIPE (private placements in public equities) funds. GeneChem usually puts resources into genomics with focus on gene discovery, functional genomics, bioinformatics, proteomics, and gene therapy among others.

Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia approved a suggestion from Golden's AI on 11 Nov, 2019
Edits made to:
Article (+15/-15 characters)
Article

GeneChem is a venture capita firm that centers on biotechnology venture capitalventure capital funds. They have over $350M in assets circulated in four finds: GeneChem Technologies, GeneChem Therapeutics, Agechem and AmorChem. Since 1997, GeneChem has been active in putting resources into companies that are focused on drug discovery and development. They have put resources into more than 60 companies situated in the US, Canada and Europe.

Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia approved a suggestion from Golden's AI on 11 Nov, 2019
Edits made to:
Article (+6/-6 characters)
Article

GeneChem is a venture capita firm that centers on biotechnology venture capital funds. They have over $350M in assets circulated in four finds: GeneChem Technologies, GeneChem Therapeutics, Agechem and AmorChem. Since 1997, GeneChem has been active in putting resources into companies that are focused on drug discovery and development. They have put resources into more than 60 companies situated in the US, CanadaCanada and Europe.

Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia approved a suggestion from Golden's AI on 11 Nov, 2019
Edits made to:
Article (+8/-8 characters)
Article

GeneChem is a venture capita firm that centers on biotechnology venture capital funds. They have over $350M in assets circulated in four finds: GeneChem Technologies, GeneChem Therapeutics, Agechem and AmorChemAmorChem. Since 1997, GeneChem has been active in putting resources into companies that are focused on drug discovery and development. They have put resources into more than 60 companies situated in the US, Canada and Europe.

Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia approved a suggestion from Golden's AI on 11 Nov, 2019
Edits made to:
Article (+6/-6 characters)
Article

GeneChem is a venture capita firm that centers on biotechnology venture capital funds. They have over $350M in assets circulated in four finds: GeneChem Technologies, GeneChem Therapeutics, Agechem and AmorChem. Since 1997, GeneChem has been active in putting resources into companies that are focused on drug discovery and development. They have put resources into more than 60 companies situated in the US, Canada and EuropeEurope.

Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia approved a suggestion from Golden's AI on 11 Nov, 2019
Edits made to:
Article (+8/-8 characters)
Article

GeneChem is headquartered in MontrealMontreal, Quebec. It has an income of $2.5M, and has 10 employees. It has obtained around $44.2M in funds. It has 9 companies in its portfolio. It takes part in everything from seed and startup financings to later stage mezzanine rounds to PIPE (private placements in public equities) funds. GeneChem usually puts resources into genomics with focus on gene discovery, functional genomics, bioinformatics, proteomics, and gene therapy among others.

Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia edited on 11 Nov, 2019
Edits made to:
Article (+2/-1 characters)
Article

GeneChem is a venture capita firm that centers on biotechnology venture capital funds. They have over $350M in assets circulated in four finds: GeneChem Technologies, GeneChem Therapeutics, Agechem and AmorChem. Since 1997, GeneChem has been active in putting resources into companies that are focused on drug discovery and development. They have put resources into more than 60 companies situated in the US, Canada and Europe.

Edits on 11 Nov, 2019
Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia edited on 11 Nov, 2019
Edits made to:
Article (-19 characters)
Companies (+4 rows) (+4 cells) (+81 characters)
Article

GeneChem is headquartered in Montreal, Quebec. It has an income of $2.5M, and has 10 employees. It has obtained around $44.2M in funds. It has 9 companies in its portfolio, including Sorbent. It takes part in everything from seed and startup financings to later stage mezzanine rounds to PIPE (private placements in public equities) funds. GeneChem usually puts resources into genomics with focus on gene discovery, functional genomics, bioinformatics, proteomics, and gene therapy among others.

Companies

Company
CEO
Location
Products/Services

Ambit Biosciences

NuChem Therapeutics

Osprey Pharmaceuticals USA

Sonexa Therapeutics

Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia edited on 11 Nov, 2019
Edits made to:
Description (+115/-154 characters)
Article (+925/-382 characters)

GeneChem

GeneChem is a manager of specialised biotechnology venture capital funds which include AmorChem, AgeChem, GeneChem Technologies and GeneChem Therapeutics.

Venture capital firm from Quebec, Canada investing in companies that are involved in drug discovery and development

Article

GeneChem is a manager of focused biotechnology venture capital funds. They have over $350M in assets distributed over four funds: GeneChem Technologies, GeneChem Therapeutics, Agechem and AmorChem. Since 1997, GeneChem has been active in investing in companies involved in drug discovery and development. They have invested in over 60 companies located in the US, Canada and Europe.

GeneChem is a venture capita firm that centers on biotechnology venture capital funds. They have over $350M in assets circulated in four finds: GeneChem Technologies, GeneChem Therapeutics, Agechem and AmorChem. Since 1997, GeneChem has been active in putting resources into companies that are focused on drug discovery and development. They have put resources into more than 60 companies situated in the US, Canada and Europe

GeneChem is headquartered in Montreal, Quebec. It has an income of $2.5M, and has 10 employees. It has obtained around $44.2M in funds. It has 9 companies in its portfolio, including Sorbent. It takes part in everything from seed and startup financings to later stage mezzanine rounds to PIPE (private placements in public equities) funds. GeneChem usually puts resources into genomics with focus on gene discovery, functional genomics, bioinformatics, proteomics, and gene therapy among others.

Edits on 7 Nov, 2019
Carla Faraguna
Carla Faraguna edited on 7 Nov, 2019
Edits made to:
Infobox (+3 properties)
Description (+154 characters)
Article (+382 characters)

GeneChem

GeneChem is a manager of specialised biotechnology venture capital funds which include AmorChem, AgeChem, GeneChem Technologies and GeneChem Therapeutics.

Article

GeneChem is a manager of focused biotechnology venture capital funds. They have over $350M in assets distributed over four funds: GeneChem Technologies, GeneChem Therapeutics, Agechem and AmorChem. Since 1997, GeneChem has been active in investing in companies involved in drug discovery and development. They have invested in over 60 companies located in the US, Canada and Europe.

Infobox
Full address
1 Westmount Square, Suite 800, Montreal, Quebec, H3Z 2P9
Industry
Biotechnology
Edits on 7 Nov, 2019
Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia edited on 7 Nov, 2019
Edits made to:
Infobox (+2/--1 properties)
People (+4 rows) (+8 cells) (+145 characters)
People

Name
Role
LinkedIn

Fabienne Perreau

Administrative Assistant

Inès Holzbaur

General Partner

Maxime Pesant

Vice-President, Finance

Patricia Laplante

Project Manager

Infobox
Location
Canada
Company status
Active
Founded date
1997
Edits on 11 Jul, 2019
Golden AI"Crunchbase 2013 Snapshot (C) 2013 https://data.crunchbase.com/docs/2013-snapshot#section-using-the-snapshot"
Golden AI edited on 11 Jul, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Is a
Company
Edits on 9 Jul, 2019
Golden AI"Crunchbase 2013 Snapshot (C) 2013 https://data.crunchbase.com/docs/2013-snapshot#section-using-the-snapshot"
Golden AI edited on 9 Jul, 2019
Edits made to:
Infobox (+3 properties)
Infobox
Is a
Venture capital firm
Golden AI"Initial topic creation"
Golden AI created this topic on 9 Jul, 2019
Edits made to:

 GeneChem

Venture capital firm from Quebec, Canada investing in companies that are involved in drug discovery and development

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.